Treatment of heart failure with beta-adrenergic blocking drugs;Betablokkerbehandling av hjertesviktpasienter

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 4, 1997, Pages 526-528

  Gundersen, Torstein ^a   Dickstein, Kenneth ^b   Hole, Torstein ^c   Kjekshus, John ^d   Myhre, Eivind S P ^e   Rønnevik, Per ^f   Smith, Pål ^b   Westheim, Arne ^g  

^a Medisinsk Avdeling   (Norway)

^b Sentralsjukehuset i Rogaland ^*  (Norway)

^c Medisinsk Avdeling   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Medisinsk Avdeling   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g Hjerteavdelingen   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; PROPRANOLOL; TIMOLOL;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; SHORT SURVEY;

ADRENERGIC BETA-ANTAGONISTS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0030748762     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. Dargie HJ, McMurrey JJV. Diagnosis and management of heart failure. BMJ 1994; 308: 321-8.
2. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis G et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 1984; 311: 819-23.
3. Gottlieb SS, Kukin ML, Ahem D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic congestive heart failure. J Am Coll Cardiol 1989; 13: 1534-9.
4. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS study group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-6.
5. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35.
6. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10.
7. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
8. Pfeffer MA, Braunwald E, Mové LA, Basta L, Brown EJ, Cuddy TE, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-77.
9. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
10. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-7.
11. Gundersen T, Trætteberg K, Rønnevik P, von Brandis C, Barstad S, Abrahamsen AM. Changes in heart size during long-term timolol treatment after myocardial infarction. Acta Med Scand 1984; 215: 33-41.
12. Vedin A, Wilhelmsen L, Wedel H, Pettersson B, Wilhelmsson C, Elmfeldt D et al. Prediction of cardiovascular deaths and nonfatal reinfarction after myocardial infarction. Acta Med Scand 1977; 201: 309-16.
13. Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J 1983; 50: 135-9.
14. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after myocardial infarction in patients with congestive heart failure. Circulation 1986; 73: 503-10.
15. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-36.
16. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979; 2: 1374-6.
17. Engelmeier RS. O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy, a double-blind, randomized, placebo-controlled trial. Circulation 1985; 72: 536-46.
18. Bashir Y, McKenna WJ, Camm AJ. Beta blockers and the failing heart: is it time for a U-turn? Br Heart J 1993; 70: 8-12.
19. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA et al, for the Metoprolol in Dilated Cardiomyopathy (MCD) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 2: 1441-6.
20. CIBIS Investigators and Committees. A randomized trial of beta blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765-73.
21. Eichorn EJ, Bedotto JB, Malloy CR, Hatfield BA. Beta-adrenergic blockade on myocardial function and energestics in congestive heart failure Circulation 1990; 82: 473-83.
22. Bristow MR, O'Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE et al. for the Bucindolol Investigators. Dose-respons of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation 1994; 89: 1632-42.
23. Ruffolo RR, Boyle DA, Brooks DP. Carvedilol: a novel cardiovascular drug with multiple actions. Cardiovasc Drug Rev 1992; 10: 127-57.
24. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hersberger R et al, for the MOCHA Investigators. Multicenter oral carvedilol heart failure assessment (MOCHA): a six-month dose-response evaluation in class II-IV patients. Circulation 1995; 92 (suppl 1): 1-142.
25. Australia-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995; 92: 212-8.
26. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al, for the U.S. Carvedilol Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
27. Pouleur H, Benedict CR, Rousseau MF. Neurohormones in patients with ischemic left ventricular dysfunction. Cardiovasc Drugs Ther 1994; 8 (suppl 2): 313-7.
28. Bristow MR, Ginsburg R, Minobe W. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. Cardiovasc Drugs Ther 1994; 8: 115-8.
29. Gundersen T, Grattum P, Pedersen T, Kjekshus JK, for the Norwegian Multicenter Timolol Study Group. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986; 58: 20-4.
30. Packer M. Treatment of chronic heart failure. Lancet 1992; 340: 92-5.